Cytokeratins and cell differentiation in the pancreas

Journal of Pathology

Volumn 184, Issue 3, 1998, Pages 234-239

  Bouwens, L ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

Ducts; Exocrine; Immunohistochemistry; Intermediate filaments; Islets of Langerhans; Keratin; Pancreas; Review

Indexed keywords

CYTOKERATIN; CYTOKERATIN 19; INTERMEDIATE FILAMENT PROTEIN; KERATIN; POLYPEPTIDE;

ACINAR CELL; ANIMAL CELL; ANIMAL TISSUE; CELL DIFFERENTIATION; CONTROLLED STUDY; EXOCRINE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MORPHOGENESIS; MOUSE; NONHUMAN; PANCREAS CELL; PANCREAS DUCT; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW; SPECIES DIFFERENCE; SWINE;

BIOLOGICAL MARKERS; CELL DIFFERENTIATION; HUMANS; KERATINS; PANCREAS; PANCREATIC DISEASES; PANCREATIC DUCTS;

EID: 0031914251     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199803)184:3<234::AID-PATH28>3.0.CO;2-D     Document Type: Review

References (35)

1. Moll R, Franke WW, Schiller DL. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 11-24.
2. Albers K, Fuchs E. The molecular biology of intermediate filament proteins. Int Rev Cytol 1992; 134: 243-279.
3. Moll R, Löwe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992; 140: 427-447.
4. Ku NO, Michie S, Oshima RG, Omary MB. Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant. J Cell Biol 1995; 131: 1303-1314.
5. Ramaekers F, Huysmans A, Schaart G, Moesker O, Vooijs P. Tissue distribution of keratin 7 as monitored by a monoclonal antibody. Exp Cell Res 1987; 170: 235-249.
6. Kasper M, Hahn von Dorsche H, Stosiek P. Changes in the distribution of intermediate filament proteins and collagen IV in fetal and adult human pancreas. Histochemistry 1991; 96: 271-277.
7. Schüssler MH, Skoudy A, Ramaekers F, Real FX. Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer. Am J Pathol 1992; 140: 559-568.
8. Real FX, Vila MR, Skoudy A, Ramaekers FCS, Corominas JM. Intermediate filaments as differentiation markers of exocrine pancreas. II. Expression of cytokeratins of complex and stratified epithelia in normal pancreas and in pancreas cancer. Int J Cancer 1993; 54: 720-727.
9. Santini D, Ceccarelli C, Martinelli GN, et al. Expression of intermediate filaments in normal and neoplastic exocrine pancreas. Zentralbl Pathol 1994; 140: 247-258.
10. Bouwens L, Braet F, Heimberg H. Identification of rat pancreatic duct cells by their expression of cytokeratins 7, 19 and 20 in vivo and after isolation and culture. J Histochem Cytochem 1995; 43: 245-253.
11. Bouwens L, Lu WG, De Krijger R, Pipeleers D. Keratins as markers of duct-to-islet cytodifferentiation in fetal pancreas. Diabetologia 1996; 39 (Suppl 1): A63..
12. Schubart UK, Fields KL. Identification of a calcium-regulated insulinoma cell phosphoprotein as an islet cell keratin, J Cell Biol 1984; 98: 1001-1009.
13. Pinkus GS, O'Connor EM, Etheridge CL, Corson JM. Optimal immuno-reactivity of keratin proteins in formalin-fixed, paraffin-embedded tissue requires preliminary trypsinization. J Histochem Cytochem 1985; 33: 465-473.
14. Bouwens L, Lu WG, De Krijger R. Proliferation and differentiation in the human fetal endocrine pancreas. Diabetologia 1997; 40: 398-404.
15. Bouwens L, De Blay E. Islet morphogenesis and stem cell markers in rat pancreas. J Histochem Cytochem 1996; 44: 947-951.
16. Bouwens L, Wang RN, De Blay E, Pipeleers DG, Klöppel G. Cytokeratins as markers of ductal cell differentiation and islet neogenesis in the neonatal rat pancreas. Diabetes 1994; 43: 1279-1283.
17. Le Douarin NM. On the origin of pancreatic endocrine cells. Cell 1988; 53: 169-171.
18. Van Eyken P, Desmet VJ. Cytokeratins and the liver. Liver 1993; 13: 113-122.
19. Slack JMW. Developmental biology of the pancreas. Development 1995; 121: 1569-1580.
20. Bouwens L, Klöppel G. Islet cell neogenesis in the pancreas. Virchows Arch 1996; 427: 553-560.
21. Sell S, Pierce GB. Biology of disease: maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest 1994; 70: 6-22.
22. Bisgaard HC, Thorgeirsson SS. Evidence for a common cell of origin for primitive epithelial cells isolated from rat liver and pancreas. J Cell Physiol 1991; 147: 333-343.
23. Wang RN, Klöppel G, Bouwens L. Duct to islet cell differentiation and islet growth in the pancreas of duct ligated adult rats. Diabetologia 1995; 38: 1405-1411.
24. Bockman DE. Toward understanding pancreatic disease: from architecture to cell signalling. Pancreas 1995; 11: 324-329.
25. Githens S. Pancreatic duct cell cultures. Annu Rev Physiol 1994; 56: 419-443.
26. Hall PA, Lemoine NR. Rapid acinar to ductal transdifferentiation in cultured human exocrine pancreas. J Pathol 1992; 166: 97-103.
27. Yoshida T, Hanahan D. Murine pancreatic ductal adenocarcinoma produced by in vitro transduction of polyoma middle T oncogene into the islets of Langerhans. Am J Pathol 1994; 145: 671-684.
28. Stasiak PC, Purkis PE, Leigh IM, Lane B. Keratin 19: predicted amino acid sequence and broad tissue distribution suggest it evolved from keratinocyte keratins. J Invest Dermatol 1989; 92: 707-716.
29. Vila MR, Lloreta J, Real FX. Normal human pancreas cultures display functional ductal characteristics. Lab Invest 1994; 71: 423-431.
30. Rooman I, Schuit F, Bouwens L. Effect of vascular endothelial growth factor on growth and differentiation of pancreatic ductal epithelium. Lab Invest 1997; 76: 225-232.
31. Pavlovic D, Van De Winkel M, Van der Auwera B, et al. Effect of Interferon-α and glucose on MHC class I and class II expression by pancreatic α and non-α cells. J Clin Endocr Metab. 1997; 82: 2329-2336.
32. Vila MR, Balague C, Real FX. Cytokeratins and mucins as molecular markers of cell differentiation and neoplastic transformation in the exocrine pancreas. Zentralbl Pathol 1994; 140: 225-235.
33. Herzig KH, Altmannsberger M, Folsch UR. Intermediate filaments in rat pancreatic acinar tumors, human ductal carcinomas, and other gastrointestinal malignancies. Gastroenterology 1994; 106: 1326-1332.
34. Kobayashi T, Nakanishi K, Kajio H, et al. Pancreatic cytokeratin: an antigen of pancreatic exocrine cell autoantibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990; 33: 363-370.
35. Simon M, Girbal E, Sebbag M, et al. The cytokeratin filament-aggregating protein filaggrin is the target of the so-called 'antikeratin antibodies', autoantibodies specific for rheumatoid arthritis. J Clin Invest 1993; 92: 1387-1393.